FAKTOR-OPTIONSSCHEIN - PROGYNY Stock

Certificat

DE000MG3D8G0

Delayed Börse Stuttgart 15:53:34 2024-05-31 EDT
14.35 EUR -4.97% Intraday chart for FAKTOR-OPTIONSSCHEIN - PROGYNY
1 month+43.36%
Date Price Change
24-05-31 14.35 -4.97%
24-05-30 15.1 -2.64%
24-05-29 15.51 +3.33%
24-05-28 15.01 +5.26%
24-05-24 14.26 -0.49%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 03:53 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying PROGYNY, INC.
Issuer Morgan Stanley
WKN MG3D8G
ISINDE000MG3D8G0
Date issued 2024-04-30
Strike 35.94 $
Maturity Unlimited
Parity 0.58 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.59
Lowest since issue 8.57
Spread 0.12
Spread %0.83%

Company Profile

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Sector
-
More about the company

Ratings for Progyny, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Progyny, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
26.95 USD
Average target price
38.56 USD
Spread / Average Target
+43.06%
Consensus